Skip to Content
About Abbott
Contact
United States | eng
Country Language
CARDIOVASCULAR
United States | eng
Country Language

Entrant™ ICD Solutions

Single and Dual Chamber Implantable Cardioverter Defibrillators

MAT-2403640 v2.0 | Item approved for U.S. use only. ©2025 Abbott. All Rights Reserved.

Entrant ICD
Join Our Email List
Contact your Abbott Rep

Powerful Therapy Assurance

Available in DF-4 and DF-1 configurations to improve quality of life for patients at every stage of therapy. 

The Entrant ICD features the smallest and lightest Bluetooth®-enabled DF-4 device on the market today.1

  • Reduce inappropriate therapy with features proven to increase detection capabilities and safety margins2,3
  • Encourage greater patient engagement with app-based remote monitoring4
  • No Wait 1.5T and 3T MRI* ensures patients can get the care they need when they need it†
MRI icon

*For additional information about specific MR Conditional devices and leads, including scan parameters, warnings, precautions, adverse conditions to MRI scanning and potential adverse events, please refer to the Abbott MRI-Ready Systems Manual.

Stay Informed

Sign up to hear about our technology, education opportunities, and more.

Join Our Email List

Read the Latest Blog Article

Stay up to date with recent news, product highlights, and case studies.

Visit the Abbott CRM Blog

References

  1. Device IFUs: Abbott Tachycardia Devices Help Manual (ARTEN600307504A), Medtronic manuals (Evera‡ XT, Amplia‡, Cobalt‡ XT, and Crome‡), Boston Scientific manuals (NG4 Tachy ICD, NG4 Tachy CRT-D), and Biotronik (Rivacor‡ ICDs and CRT-Ds, Acticor‡ ICDs and CRT-Ds).
  2. Gabriels J, Budzikowski AS, Kassotis JT. Defibrillation waveform duration adjustment increases the proportion of acceptable defibrillation thresholds in patients implanted with single-coil defibrillation leads. Cardiology. 2013;124(2):71-75.
  3. Geller JC, Wöhrle A, Busch M, et al. Reduction of inappropriate implantable cardioverter-defibrillator therapies using enhanced supraventricular tachycardia discriminators: the ReduceIT study. Journal of Interventional Cardiac Electrophysiology. 2021;61(2):339-348. doi:10.1007/s10840-020-00816-9
  4. Manyam H, Casado-Arroyo R, Lennerz C, et al. Smartphone-based CIED Remote Monitoring: Improved Compliance and Connectivity. Poster presented at: Asia Pacific Heart Rhythm Society 2021; November 11-14, 2021; Suzhou, China.

† No minimum length of time requirement between implant and MRI scan. Stability of pacing capture thresholds is required prior to MRI scan.

Bluetooth and Bluetooth logo are registered trademarks of Bluetooth SIG, Inc.

MAT-2008837 v3.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
abbott logo

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2025 Abbott. All Rights Reserved.

MAT-1900882 v14.0